drugset / Trial / NCT05658575
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Timeline
- Start
- 2023-01-06
- Primary completion
- 2026-12-31
- Completion
- 2027-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapansutrile | Small molecule | 1000 mg | — |